Atlas Trials

Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema

Clinical trial NCT07338097 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07338097
Sponsor
CMH Multan Institute of Medical Sciences
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetic Macular Edema (DME)
Start date
2025-09-07
Primary completion
2026-02-07
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.